
If you’ve heard the word entheogen floating around conversations about psychedelics, you’re not alone. It shows up in wellness circles, academic papers, and dispensary menus alike, and it rarely gets explained.
This article covers where the word came from, the plants and fungi it usually refers to and their history, how a microdose differs from a full ceremonial experience, and why the word has become shorthand for a certain kind of substance use. It also covers what all of this means if you’re in Canada and curious about microdosing mushrooms.
What the word means
An entheogen is a psychoactive substance — usually a plant or fungus — used to generate an experience of the sacred, or of something larger than the everyday self.
The word was coined in 1979 by five scholars, Carl Ruck, Jeremy Bigwood, Danny Staples, Jonathan Ott and R. Gordon Wasson, in a short paper in the Journal of Psychedelic Drugs. They wanted a term for the spiritual dimension of these substances without the baggage attached to “psychedelic” or “hallucinogen.” It’s built from Greek: entheos, “full of the god” or “inspired,” and genesthai, “to come into being.” Put together, it means roughly “generating the divine within.”
Purpose is the key idea. A substance becomes an entheogen when it’s used with intention — for insight, connection, reflection, or a sense of meaning. The same mushroom eaten absent-mindedly at a party isn’t being used as an entheogen in the strict sense.
The word describes a relationship between a person, a substance, and an intention.
Entheogen, psychedelic or hallucinogen?
The three words often get used interchangeably, but each carries its own history and its own frame.
Hallucinogen
is the older clinical term, still common in pharmacology and law. Its problem is the plain-English meaning: a hallucination is something that isn’t real, so the word quietly suggests that everything a person experiences is made up.
Psychedelic
was coined by the psychiatrist Humphry Osmond in 1956, in letters to Aldous Huxley, and means “mind-manifesting”. It’s an apt description, but the word was soon tied to the 1960s counterculture, and for many people it still sounds more like tie-dye than tradition.
Entheogen
puts the sacred at the centre. It doesn’t require you to believe in God. It asks you to take seriously that people who use these substances in ceremony understand the experience as being about something. In a 2006 Johns Hopkins study, for example, volunteers who regularly took part in religious or spiritual activities said, two months after a high-dose psilocybin session, that it had held substantial personal meaning and spiritual significance for them.
So the words overlap but don’t mean the same thing. Psilocybin mushrooms are psychedelics; they become entheogens when someone uses them for insight, connection, or growth. Roughly speaking, science says psychedelic, the law says hallucinogen, and tradition says entheogen.
A short history
Humans have worked with psychoactive plants and fungi for a very long time. Archaeological and historical evidence points to ritual use across many cultures and continents, and Indigenous peoples in the Americas and elsewhere have relationships with some of these plants that go back centuries. It isn’t our place to borrow those ceremonies or teach them here — they exist, they’re protected, and they’re meaningful within their own traditions. What we can do is point to some of the history that’s well documented.
The Mazatec of Oaxaca
In the mountains of southern Mexico, Mazatec healers hold veladas, night-time ceremonies built around psilocybin mushrooms, which they call the little saints. Spanish colonial writers had described Aztec ceremonial use of mushrooms called teonanácatl, usually translated as “flesh of the gods,” with the aim of stamping it out. The practice survived anyway. In 1955 the banker and amateur mycologist R. Gordon Wasson took part in a velada led by the curandera Maria Sabina, and his 1957 article in Life magazine brought the mushrooms to wide Western attention. Our article on Maria Sabina and the velada tells that story in full.
Eleusis
For many centuries in ancient Greece, initiates walked from Athens to Eleusis for the Mysteries of Demeter and Persephone. They drank a barley drink called kykeon and went through an experience they were forbidden to describe. In 1978, Wasson, the chemist Albert Hofmann and the classicist Carl Ruck argued in The Road to Eleusis that the drink contained ergot, a fungus that grows on grain. The theory is still debated, and nobody knows for certain what was in the cup. Our piece on the Eleusinian Mysteries goes deeper.
The Vedic soma
A whole book of the Rigveda, one of the oldest Hindu texts, is devoted to soma, a pressed plant drink at the centre of early Vedic ritual. Wasson proposed in 1968 that soma was the fly agaric mushroom, Amanita muscaria; many scholars favour ephedra instead. The question is unsettled, and it’s a good example of how easily a confident theory hardens into “fact.” We look at that pattern in the ancient mushroom myth.
The Western story is much shorter. After Wasson’s article, the following decade saw a burst of research and clinical interest. The political crackdown of the 1970s pushed nearly all of it underground, and that’s where things stayed for decades.
The word entheogen emerged from that underground period. It was partly an attempt by scholars and practitioners to reframe these substances as tools for spiritual and psychological exploration rather than mere intoxicants.
The last decade has seen a quiet reversal. Psilocybin is being studied again at respected institutions — Johns Hopkins and Imperial College London both now have dedicated psychedelic research centres — and public attitudes have shifted considerably. A middle ground has opened between “illegal party drug” and “sacred medicine guarded by tradition,” and microdosing lives in that middle ground.

The best-known entheogens
Here is a short guide to the main entheogens, with a note on where each stands under Canadian law as of November 2026. When people in Canada talk about entheogens today, they usually mean psilocybin mushrooms, the most accessible and widely discussed of the group, so that’s where we start.
Psilocybin mushrooms
Psilocybin is found in many species of mushroom around the world, most famously in the Psilocybe genus. The body converts it to psilocin, the compound behind its effects. The Mazatec tradition described above is the best documented of the ceremonial traditions built around these mushrooms. In Canada, psilocybin and psilocin are both listed in Schedule III of the Controlled Drugs and Substances Act. For the chemistry and the details, see our guide to what psilocybin is.
Ayahuasca and DMT
Ayahuasca is a brew, not a single plant. It’s usually made from the Banisteriopsis caapi vine and the leaves of Psychotria viridis or a similar plant. The leaves supply DMT, which the body breaks down quickly when it’s swallowed on its own; the vine supplies harmala alkaloids that block that breakdown. Indigenous peoples of the western Amazon developed the brew, and in the 20th century Brazilian religious movements such as Santo Daime built their own rituals around it. It’s often described as ancient, but the first clear written accounts date from the 17th century, and it may have spread across the region only in the last few centuries.
In Canada, DMT, harmaline and harmalol are all Schedule III substances. In 2017, the Santo Daime church Céu do Montréal received a federal exemption to serve ayahuasca as a sacrament in its ceremonies. The exemption covers that group only, not ayahuasca in general.
Because the vine’s alkaloids are MAO inhibitors, ayahuasca can interact dangerously with SSRIs and other antidepressants, with a range of other medications, and with some foods, which is one reason traditional preparation often includes a restricted diet.
Peyote and San Pedro
Peyote (Lophophora williamsii) is a small, slow-growing cactus from the Chihuahuan Desert of northern Mexico and southern Texas. Its main active compound is mescaline. For the Wixárika (Huichol) people of Mexico, peyote is at the heart of their religion. The Native American Church, formally established in 1918, uses it as a sacrament in all-night ceremonies, and in the United States federal law has protected traditional ceremonial use of peyote by Native Americans since 1994. Mescaline was also the subject of Aldous Huxley’s 1954 book The Doors of Perception, which introduced many Western readers to the idea of these experiences. Today peyote is listed as vulnerable on the IUCN Red List, which is worth knowing before anyone treats it as a commodity.
San Pedro (Echinopsis pachanoi) is its fast-growing Andean relative. It also contains mescaline, and archaeological finds link it to ancient Peruvian cultures including the Chavín, Moche and Nazca. Healers in northern Peru still prepare it today. In Canada, mescaline is a Schedule III substance, but the schedule names peyote itself as an exception.
Iboga and ibogaine
Iboga (Tabernanthe iboga) is a shrub from Central Africa. Its root bark is central to Bwiti, a spiritual tradition in Gabon, and European explorers first wrote about that ceremonial use in the 19th century. Its main alkaloid, ibogaine, produces a long experience, often lasting well over a day at full doses, and it has drawn research interest in the West.
Ibogaine also carries real risks, especially to heart rhythm. Health Canada has received reports of serious and fatal reactions, and in 2017 it added ibogaine to the Prescription Drug List. It isn’t listed in the Controlled Drugs and Substances Act.
Blue lotus
The blue lotus, or blue water lily (Nymphaea caerulea), is native to much of eastern Africa, including the Nile. It appears again and again in ancient Egyptian art and mythology as a symbol of the sun and rebirth, and it has been found in pharaohs’ tombs. Whether Egyptians used it for its effects, and how, is still argued over. The flower contains the alkaloid nuciferine, and traces of the plant have been identified in an Egyptian ritual vase from the 2nd century BCE. Blue lotus isn’t listed in the schedules of the Controlled Drugs and Substances Act.
Salvia divinorum
This sage from the cloud forests of Oaxaca is used by Mazatec healers for divination. Its active compound, salvinorin A, acts on a different receptor system from every other substance here, and people describe the experience as short and often disorienting. In Canada, it’s listed in Schedule IV of the Controlled Drugs and Substances Act.
What connects all of these, across continents and very different chemistry, is the context of use. A substance becomes an entheogen because of what people do with the experience: the preparation, the ceremony, the intention, and the integration afterward. Culture after culture arrived at a similar idea on its own: the setting matters as much as the substance.
Why people use the word now
A few things are going on.
Language shapes framing. “Drugs” carries a stigma, and the older words carry the baggage described above. As more people use psilocybin for purposes that are neither recreational thrill-seeking nor formal therapy, they’ve needed a word for that middle category, and entheogen is the best one available.
There’s also the wellness mainstreaming of psychedelics. Interest in microdosing has grown well beyond the communities that historically used these substances, and the vocabulary has travelled with it. Journalists, podcasters, and researchers reach for entheogen when they want to be precise about the difference between intentional use and casual use.
Finally, there’s the argument — made by plenty of thoughtful people — that the word helps correct a historical injustice in how these substances were described. For decades the dominant framing was purely about danger and intoxication, which erased centuries of respectful, structured, meaningful use. Calling them entheogens is a small way of acknowledging that history without appropriating it.
How a small dose differs from a ceremonial one
A microdose and a ceremonial dose are genuinely different experiences.
A ceremonial or full dose of psilocybin mushrooms — often several grams — produces a pronounced altered state. Perception changes, thought patterns shift, and the experience can last four to six hours or more. In traditional settings, experiences like this are held within ceremony, guided by experienced people, and treated as significant events in a person’s life.
Even in modern, non-traditional settings, a full dose is usually approached with preparation, a safe environment, and time set aside for integration afterward.
A microdose is a sub-perceptual amount — typically a tenth or less of a recreational dose — taken on a schedule rather than as an occasion. You don’t trip, you don’t see visuals, and you don’t dissolve into a mystical experience. Some people describe the effect, if they notice anything at all, as subtle: a little more focus or ease in their day.
The aim, as people describe it, isn’t to leave ordinary reality but to stay inside it.
That distinction explains a few things. Microdosing has caught on with people who would never plan a full-dose experience, because it fits into a workday, a parenting schedule, a normal life. And a microdose doesn’t substitute for a ceremony — anyone who tells you it’s a shortcut to the deep experiences ceremonial doses can produce is selling something.
A microdose is also far less impairing than a full dose, though the risks don’t drop to zero. More on that shortly.
For many curious adults, microdosing is the sensible entry point. It lets you explore how psilocybin interacts with your particular mind and body without committing to an intense experience. And if you decide to continue, quality products with consistent dosing make the practice far more predictable than foraging ever could.
A caveat worth taking seriously
Psilocybin can interact badly with certain medications — particularly psychiatric medications like SSRIs and MAOIs and, more seriously, lithium. If you take any prescription medication, talk to a doctor or pharmacist before microdosing; our guide to psilocybin and drug interactions covers the main ones. Some of these interactions matter, and this isn’t a decision to make from a blog post, including this one.
If you have a personal or family history of psychosis, schizophrenia, or bipolar disorder, psychedelics of any dose are generally considered a bad idea. The research on microdosing specifically is thinner than the research on full doses, so caution is warranted.
And “sub-perceptual” doesn’t mean “no effect.” Some people feel more than they expected, especially in the first week or two while finding their dose. Don’t microdose and drive until you know how it affects you, and don’t treat it as a substitute for professional care for a real mental health condition.
With those limits stated, some people say they find a careful microdosing routine worthwhile.
Canada: where things stand
Canada occupies an interesting position. The legal status of psilocybin is genuinely complicated, with layers of federal law, evolving enforcement priorities, and carve-outs for specific circumstances. Read a proper breakdown of psilocybin’s legality in Canada rather than relying on a summary.
The short version: don’t assume it’s legal, and don’t assume the law is as simple as you remember it being.
What’s clearly true is that Canadians are curious. Interest in microdosing has grown steadily, and a range of products now serves that interest. If you’re exploring, a few are worth knowing.
Bloom pairs Golden Teacher mushrooms with maca, cacao and Siberian ginseng. Brighten is the strongest capsule, Golden Teacher with schisandra berry. Holiday pairs Golden Teacher with passionflower.
Whichever you consider, treat dosing as something to learn about first, and start low.
Getting started, practically
If you’ve read the caveat and you’re still curious, the practical path is straightforward. Read up on dosing schedules — many people follow a pattern like one day on, two days off. Choose a product from a reputable source rather than guessing with raw material, and start at the low end of the range.
Keep brief notes on your energy, mood, and focus as you go.
Some people describe microdosing as a small, deliberate practice rather than a magic fix. It won’t transform your life on its own.
Curiosity is a good reason to learn about entheogens, and a good reason to try microdosing carefully too. Understand the word, respect the history, know the legal picture where you live, keep the real caveats in mind — and if you proceed, proceed deliberately.
Frequently asked questions
Is “entheogen” a legal term?
No. Canadian law doesn’t use it. The Controlled Drugs and Substances Act lists specific substances by name, such as psilocybin, DMT and mescaline, and calling something an entheogen, or using it with spiritual intent, doesn’t change its legal status. For psilocybin specifically, read our guide to psilocybin legality in Canada.
Will a microdose show up on a drug test?
Standard drug panels don’t typically test for psilocybin, but specialized tests exist. If you’re subject to testing for work or legal reasons, the only guaranteed-safe answer is not to use it at all.
How long until I notice something from microdosing?
People who report noticing anything usually describe it as gradual — a subtle shift over weeks rather than a day-one revelation. Many people give it four to six weeks before deciding. If nothing has changed by then, it may just not be for you, and that’s fine too.

Comments
There are no comments yet.